Effect of Blood Flow Restriction Technique on Postpartum Pelvic Girdle Pain

December 5, 2025 updated by: Nour Abdelaty Attia El-desouky, Kafrelsheikh University

Purpose of the study :

The purpose of the current study is investigating the effect of Blood Flow Restriction Training technique on postpartum pelvic girdle pain.

Study Overview

Detailed Description

This study is a randomized controlled trial. To fulfill its purpose, we have two groups; control group (A) and experimental group (B) are two matched postpartum pelvic girdle pain groups. While group (A) will receive a core stability exercise program, group (B) will receive core stability exercise program with blood flow restriction technique.

The primary outcome measure will be pelvic girdle pain intensity, while the secondary outcomes will include pelvic girdle-related disability, health-related quality of life, Kinesiophobia , global improvement and ASLR-RE angle.

Treatment duration will be eight weeks.

Study Type

Interventional

Enrollment (Estimated)

66

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients will be eligible for the study if they met all the following criteria:

    1. Are between 3 and 12 months postpartum.
    2. Are aged between 20 and 35 years.
    3. Have a body mass index (BMI) < 30 kg/m².
    4. Reported experiencing pelvic girdle pain-defined as pain localized between the posterior iliac crest and the gluteal fold, particularly in the vicinity of the sacroiliac joints-that either began during pregnancy or persisted after delivery .
    5. Presented with a positive Active Straight Leg Raise (ASLR) test.
    6. Showed positive findings in at least two of the following six pelvic pain provocation tests:

      • Posterior Pelvic Pain Provocation (P4/Thigh Thrust) Test
      • Patrick's (FABER) Test
      • Long Dorsal Sacral Ligament Test
      • Pelvic Compression Test
      • Pelvic Distraction (Separation) Test
      • Sacral Thrust Test

Exclusion Criteria:

  • -Patients will be excluded if they have any of the following:

    1. If they were Pregnant
    2. Known causes of pelvic girdle pain, such as fractures and rheumatism
    3. Undergone lumbar or pelvic surgery in the past
    4. Current neurological symptoms and signs in lower extremities such as lumbar radiculopathy and myelopathy
    5. Cancer
    6. Cardiovascular disease
    7. Experience with structured and supervised core or trunk exercise training programs

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Group (A)
Group (A) will receive a core stability exercise program.
Patients will receive specific core stabilizing exercises, focusing on Pelvic floor muscles ,Gluteus maximus, Gluteus Medius, specific abdominal muscles , the lumbar multifidus, and Erector spinae.
Experimental: Group (B)
Group (B) will receive core stability exercise program with blood flow restriction technique.
Patients will receive specific core stabilizing exercises, focusing on Pelvic floor muscles ,Gluteus maximus, Gluteus Medius, specific abdominal muscles , the lumbar multifidus, and Erector spinae.
Patients will receive the same core stability exercise added to Blood Flow Restriction Technique

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
pelvic girdle pain intensity ( pain index )
Time Frame: Baseline , 8 weeks and 16 weeks
In this study, pain severity will be measured using the mean of three 11-point NRS questionnaires for least, usual, and current pain over the previous 2 weeks.
Baseline , 8 weeks and 16 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
pelvic girdle-related disability
Time Frame: Baseline , 8 weeks and 16 weeks
pelvic girdle-related disability, measured by pelvic girdle questionnaire (PGQ)
Baseline , 8 weeks and 16 weeks
Health-related quality of life
Time Frame: Baseline , 8 weeks and 16 weeks
Health-related quality of life, measured by the Arabic version of European quality of life-Five-Dimension Five-Level Instrument (EQ-5d-5L)
Baseline , 8 weeks and 16 weeks
Kinesiophobia
Time Frame: Baseline , 8 weeks and 16 weeks
Kinesiophobia measured by an Arabic Tampa scale
Baseline , 8 weeks and 16 weeks
Global improvement
Time Frame: Baseline , 8 weeks and 16 weeks
Global improvement measured by global rating of change (GROC) scale
Baseline , 8 weeks and 16 weeks
Active straight leg raises repositioning error (ASLR-RE)
Time Frame: Baseline , 8 weeks and 16 weeks
ASLR-RE angle, measured by Image J
Baseline , 8 weeks and 16 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

December 12, 2025

Primary Completion (Estimated)

June 15, 2026

Study Completion (Estimated)

June 15, 2026

Study Registration Dates

First Submitted

December 5, 2025

First Submitted That Met QC Criteria

December 5, 2025

First Posted (Actual)

December 18, 2025

Study Record Updates

Last Update Posted (Actual)

December 18, 2025

Last Update Submitted That Met QC Criteria

December 5, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • KFSIRB200-813

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postpartum Pelvic Girdle Pain

Clinical Trials on Core Stability Exercise

Subscribe